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Abstract
Background: Systems medicine has become a key word in biomedical research. Although it is often referred to
as P4-(predictive, preventive, personalized and participatory)-medicine, it still lacks a clear definition and is open to
interpretation. This conceptual lack of clarity complicates the scientific and public discourse on chances, risks and
limits of Systems Medicine and may lead to unfounded hopes. Against this background, our goal was to develop
a sufficiently precise and widely acceptable definition of Systems Medicine.
Methods: In a first step, PubMed was searched using the keyword “systems medicine”. A data extraction tabloid
was developed putting forward a means/ends-division. Full-texts of articles containing Systems Medicine in title or
abstract were screened for definitions. Definitions were extracted; their semantic elements were assigned as either
means or ends. To reduce complexity of the resulting list, summary categories were developed inductively. In a
second step, we applied six criteria for adequate definitions (necessity, non-circularity, non-redundancy, consistency,
non-vagueness, and coherence) to these categories to derive a so-called précising definition of Systems Medicine.
Results: We identified 185 articles containing the term Systems Medicine in title or abstract. 67 contained at least
one definition of Systems Medicine. In 98 definitions, we found 114 means and 132 ends. From these we derived
the précising definition: Systems Medicine is an approach seeking to improve medical research (i.e. the understanding
of complex processes occurring in diseases, pathologies and health states as well as innovative approaches to drug
discovery) and health care (i.e. prevention, prediction, diagnosis and treatment) through stratification by means of
Systems Biology (i.e. data integration, modeling, experimentation and bioinformatics). Our study also revealed the
visionary character of Systems Medicine.
Conclusions: Our insights, on the one hand, allow for a realistic identification of actual ethical as well as legal issues
arising in the context of Systems Medicine and, in consequence, for a realistic debate of questions concerning its
matter and (future) handling. On the other hand, they help avoiding unfounded hopes and unrealistic expectations.
This especially holds for goals like improving patient participation which are intensely debated in the context of
Systems Medicine, however not implied in the concept.
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Background
Systems Medicine recently became a buzz word in
debates on biomedical research and future health care
[1, 2]. However, there is no consensus on the term’s
meaning. Currently, five main positions seem to do-
minate the discussion: (a) Systems Medicine is the
successor of Personalized Medicine [3, 4]; (b) Systems
Medicine is a precursor of Personalized Medicine or
P4-Medicine [3, 5]; (c) Systems Medicine is an
equivalent term for Precision Medicine [4]; (d) Sys-
tems Medicine means the translation of Systems Biol-
ogy into medical practice [3, 5–7]; and (e) Systems
Medicine is an “assemblage of scientific strategies and
practices that include bioinformatics approaches to
human biology […]; ‘big data’ statistical analysis; and
medical informatics tools” [8].
This divergence in understanding is, however, prob-
lematic as it complicates sound debates on chances, risks
and limits of Systems Medicine. Moreover, it is difficult
to identify and solve ethical as well as legal issues that
could arise in the context of Systems Medicine. As a
consequence, it is impossible to discuss questions of its
matter and (future) handling. Finally, the term’s under-
specification may lead to unfounded hopes of patients,
for instance, regarding the possibilities of Systems
Medicine approaches [6, 9]. Against this background, it
becomes clear why it is still seen as one of the key chal-
lenges to define Systems Medicine [6].
The goal of this paper is to develop a sufficiently pre-
cise, formally adequate definition of Systems Medicine.
Hurley [10] differentiates, among others, between stipu-
lative, lexical and précising definitions. While a lexical
definition captures the way a word is commonly used, a
stipulative definition arbitrarily assigns a meaning to a
certain expression, whereas a précising definition tries to
reduce the vagueness of a term used in practice [11].
Hence, a précising definition is geared to the everyday
usage of a term while, at the same time, it aims at
standardizing, harmonizing and structuring the different
occurring meanings in everyday usage with regard to
formal criteria for adequate definitions.
As the term Systems Medicine is already established in
everyday usage, however divergently understood, in the
following we develop a précising definition. For this pur-
pose, first, the usage of Systems Medicine in the relevant
scientific literature was analyzed and, second, harmo-
nized by appealing to formal criteria in order to develop
a formally adequate definition of Systems Medicine.
Methods1
In order to identify definitions in the relevant scientific
publications on Systems Medicine and provide an overall
picture of the research field, we followed the approach
of a systematic literature review [12, 13]. We therefore
searched PubMed using the keyword “systems medi-
cine”. We focused on PubMed as we were interested in
definitions of Systems Medicine virulent in the scientific
context. We did not include MeSH-terms in the search
strategy as the thesaurus of the US National Library of
Medicine relates “systems medicine” to the term “system
analysis”, which is defined as “[t]he analysis of an acti-
vity, procedure, method, technique, or business to deter-
mine what must be accomplished and how the necessary
operations may best be accomplished”.2 Including
MeSH-terms would therefore have pre-selected certain
articles according to this understanding of systems ana-
lysis. Excluding MeSH-terms, on the contrary, allowed
us to stay open to alternative understandings of Systems
Medicine. We only searched titles and abstracts to iden-
tify those articles in which Systems Medicine is the main
focus. Moreover, we assumed that those articles were
more likely to contain a definition. We did not restrict
the date of publication; our last search was performed
on December 31, 2015. Furthermore, we included only
articles written in English as our goal was to capture the
international debate. Subsequently, we checked full-text
availability of the articles identified. Where full-texts
were not available, we contacted the respective authors.
Step 1: Description of the areas of application of systems
medicine
To describe the areas of application of Systems Medi-
cine, in a first step, all papers fitting our search strategy
were assigned to deductively developed main categories
based on general presuppositions regarding content
alignment of the papers. These main categories are: 1)
with reference to disease and 2) without reference to dis-
ease. This distinction was made in order to evaluate the
current state of clinical application of Systems Medicine.
Several subcategories of category 1) were developed in-
ductively based on specific findings from the papers to
ensure representing the whole spectrum of diseases dealt
with in the articles. Due to the inductive approach, the
classification of the diseases was mainly based on terms
and references used in the articles and does not refer to
a specific disease ontology. However, by categorizing the
specific diseases we generally distinguish between
chronic, non-cancer diseases and hematological and
solid cancers as well as various (unspecified) forms of
disease in order to examine the areas of application of
Systems Medicine. In main category 2), those papers
were included which have no reference to any disease or
context of disease.
The first categorization showed that papers with as
well as without reference to disease can be further
specified with regard to their content alignment: they
are either research-related or programmatic articles, i.e.
both types of papers only partially relate to a specific
Schleidgen et al. BMC Health Services Research  (2017) 17:761 Page 2 of 16
context of disease. Accordingly, in a second step, all pa-
pers were assigned to the inductively developed main
categories A) research context and B) programmatic
context based on their content alignment. Category A)
includes papers which present own findings or (new)
methods in the fields of basic research, clinical research
or translational research and/or discuss results of other
research projects in these fields. Basic research was de-
fined as research conducted to increase fundamental
knowledge and understanding of physical, chemical or
functional mechanisms of life processes and diseases,
thereby providing the foundation for clinical research.
Clinical research was understood as patient-oriented re-
search, conducted with human subjects (or on material
of human origin) including inter alia research on mecha-
nisms of human disease, therapeutic interventions, and
the development of new technologies as well as epidemi-
ologic and behavioral studies or health services research.
Translational research fosters the multidirectional
integration of basic research, clinical research, and
population-based research applying basic research to hu-
man subjects and moving discoveries and knowledge
into initial clinical testing. It can be described as
mechanism-oriented clinical research that may include
laboratory-based research aimed at clarifying mecha-
nisms of disease, developing drugs etc. [14, 15]. Category
B) contains papers which focus on the description of
general potentials and challenges as well as expectations
and future prospects of Systems Medicine. These include
visions of a better or more comprehensive disease un-
derstanding and management as well as visions of gen-
eral possibilities for translation and implementation of
Systems Medicine in clinical practice.
In a third step, categories 1) and 2) were crossed with
categories A) and B), in order to evaluate the current
state of research on Systems Medicine in general as well
as in specific contexts of disease.
In a final step, the temporal distribution of publica-
tions within the categories 1), 2), A) and B) was exam-
ined. The aim thereby was to determine possible trends
over time within scientific literature regarding Systems
Medicine’s areas of application.
Step 2: Reconstruction of current systems medicine
definitions
In order to reconstruct the usage of defining Systems
Medicine, two researchers, Christoph Schickhardt and
Sebastian Schleidgen, independently screened full-texts
of the papers fitting our search strategy for definitions.
Included were not only explicit definitions of Systems
Medicine, but also text passages containing definition-
like descriptions or characterizations of Systems
Medicine. In case their assessments differed, discrepan-
cies were discussed and resolved consensually (thereby
ensuring inter-coder reliability). Subsequently, as a pre-
requisite for developing a précising definition of Systems
Medicine, a data extraction tabloid was developed which
puts forward a means/ends-distinction. This decision is
based on the following two assumptions: first, medicine
is a field of action, in which certain goals or intentions
are pursued by applying certain means or methods.
Against this background, medical applications can be de-
fined by the means they employ to reach certain ends
[16]. Second, putting forward a means-ends distinction
appears to be an adequate way to arrange the multiple
semantic elements of Systems Medicine definitions in
order to evaluate them regarding their potential for a
précising definition of Systems Medicine. Christoph
Schickhardt, Sebastian Schleidgen and Henrike Fleischer
arranged the definitional elements found in the literature
according to the extraction tabloid resulting in a list of
ends and means constitutive for the use of the term of
Systems Medicine. For instance, from the definition “sys-
tems medicine is an emerging discipline that aims to
find novel diagnostic markers and therapeutic targets by
combining omics with bioinformatics” [17] there were
derived the ends “to find novel diagnostic markers” and
“to find therapeutic targets” as well as the means of
“combining omics with bioinformatics”.
Step 3: Development of a précising definition of systems
medicine
For the purpose of developing a précising definition of
Systems Medicine intending to reduce the vagueness of
its usage in practice, we referred to six formal criteria
for adequate definitions. These criteria are:
1. necessity (a definition must be necessary, i.e. there
must not exist any well-established term equivalent
with its definiens),3
2. non-circularity (a definition must not be circular, i.e.
the definiendum must not appear in the definiens),
3. non-redundancy (a definition must not be
redundant, i.e. it must not contain any components
which are implied by any other of its components),
4. consistency (a definition must not be inconsistent,
i.e. it must not include any logical contradictions),
5. non-vagueness (a definition must not be vague, i.e.
the definiens’ meaning must be clear), and
6. coherence (a definition must be coherent, i.e. its
single semantic elements must reciprocally underpin
each other so that their combination makes sense
and is plausible) [10, 11, 16, 18].
An adequate précising definition has to satisfy all six
criteria, i.e. the whole definition (its semantic compo-
nents and their relations) must satisfy them. This is the
kind of definition we aim at developing in the following.
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In order to develop such a definition, most criteria can
be used to assess the single components derived in step 2
before evaluating the whole definition, i.e. to exclude the
ends and means found in the literature which are not
eligible for a précising definition of Systems Medicine.
The criterion of non-circularity (2), for instance, can be
applied to single terms like “systems approach”, which is
not eligible as definitional element of Systems Medicine
as the definiens must not contain any central terms of
the definiendum. Other criteria like consistency (4) or
coherency (6), however, can only be applied to predica-
tive units of meaning. Thus, the criteria (2)–(6) can be
applied to preselect potential components (single terms
or predicative units of meaning, respectively) of a précis-
ing definition of Systems Medicine.
Accordingly, we applied the criteria to the ends and
means of Systems Medicine found in the literature and
assigned the remaining ends and means to categories.
This does not mean to accept the ends and means iden-
tified in this step as ultimately eligible for a précising
definition of Systems Medicine. Rather, in view of the
criterion of coherence (6), we started an iterative
process, compared the ends and means at several stages
of our analysis with the goal of establishing a meaningful
equilibrium between them and finally approached a pré-
cising definition of Systems Medicine.
Results
General results
We identified 185 articles containing the term “systems
medicine” in title or abstract. 3 papers were not written
in English, but in Chinese, German and Italian, and
therefore excluded from further analysis. We screened
the remaining 182 articles. 67 contained at least one def-
inition of Systems Medicine and were thus included in
steps 2 and 3 of our review (see also Fig. 1).4
In our sample, Systems Medicine was first mentioned
in 1992 [19], but the discourse on Systems Medicine did
not substantially intensify before 2010/2011. Figure 2
shows the annual number of papers containing the term
“systems medicine” in title or abstract in the period of
1992–2015.
The average growth rate of literature written on Sys-
tems Medicine was about 41% per year. This is substan-
tially higher than the annual increment of PubMed’s
database in the period of 1993–2015, whose average
growth rate was 5%.
Step 1: Description of the areas of application of systems
medicine
The reviewed papers (N = 182) were assigned to the two
main categories 1) with reference to disease and 2) with-
out reference to specific disease as follows: 77 papers
Records identified through 
database searching
(Systems Medicine) 
(n = 185)
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Records excluded 
(no access)
(n = 0)
Full-text articles assessed 
for eligibility 
(n = 182)
Full-text articles excluded 
(containing no definition)
(n = 115)
Articles included in 
analysis 
(n = 67)
Records excluded 
(not English)
(n = 3)
Fig. 1 Flow diagram of data collection process according to the PRISMA statement [42]
Schleidgen et al. BMC Health Services Research  (2017) 17:761 Page 4 of 16
were assigned to main category 1), 105 papers to main
category 2). This frequency distribution shows that 58%
of the papers have no reference to specific diseases.
With regard to the specific contexts of disease men-
tioned in the articles, the literature review reveals that
chronic, non-cancer diseases (n = 35) as well as
hematological and solid cancers (n = 33) are the most fre-
quent foci of Systems Medicine (see Table 1). The
subcategory chronic, non-cancer diseases includes a var-
iety of diseases. Pulmonary and respiratory diseases (n =
12), metabolic and nutritional disorders (n = 6), psychiatric
and behavioral disorders (n = 5) are examined particularly
frequently. The third subcategory various types of diseases
includes papers not specifying the examined diseases as
chronic or non-chronic. It consists of 9 papers. Within
this subcategory, immune disorders (n = 4) are investi-
gated most frequently. Overall, the frequency distribution
of the papers shows that with regard to a single context of
disease, Systems Medicine currently is most frequently
focused on cancer research. With regard to content align-
ment, 100 papers were assigned to category A) research
context, 82 articles to category B) programmatic context.
Category A) includes 56 papers with reference to disease,
44 papers without reference to specific disease, which
means that almost half of the research-related papers do
not refer to a specific disease. Furthermore there are some
disease-related articles (n = 21), which do not present or
discuss findings or (new) methods of Systems Medicine
and thus are classified as programmatic. Of all papers allo-
cated to category B) programmatic context, 61 papers
have no reference to disease. All articles in category B) are
formulated in a very general manner meaning they are not
related to any specific research methods or findings.
Several papers are of a more advertising nature, others
have a more basic informative intent.
Table 1 depicts the frequencies of papers assigned to
categories 1) and 2), A) and B) as well as the resulting
frequencies from crossing the categories:
The temporal distribution of papers indicates that
there are no major scientific changes regarding the-
matic focus. Focusing on the articles published within
the last five years, we found that the number of
papers increased in all four categories approximately
to the same extent. The same holds for the crossed
categories.5
Fig. 2 Annual number of papers containing “Systems Medicine” (1992–2015)
Table 1 Areas of application of Systems Medicine: frequency
distribution (N = 182)
A) Research
context
(n = 100)
B) Programmatic
context
(n = 82)
1) With reference to disease (n = 77) 56 21
Cancer, hematological and solid
(n = 33)
27 6
Chronic, non-cancer diseases (n = 35) 22 13
- Pulmonary and respiratory diseases
(n = 12)
5 7
- Metabolic and nutritional disorders
(n = 7)
6 1
- Psychiatric and behavioral disorders
(n = 5)
5 /
- Cardiovascular Diseases (n = 4) 1 3
- Neurological diseases (n = 4) 2 2
- Gastrointestinal diseases (n = 3) 3 /
Various types of diseases (n = 9) 7 2
- Immune disorders (n = 4) 4 /
- Influenza (n = 1) 1 /
- Traumatic brain injury (n = 1) 1 /
- Sepsis (n = 1) / 1
- Allergy (n = 1) / 1
- Musculoskeletal Diseases (n = 1) 1 /
2) Without reference to specific disease
(n = 105)
44 61
Schleidgen et al. BMC Health Services Research  (2017) 17:761 Page 5 of 16
Step 2: Reconstruction of current systems medicine
definitions
There seems to be no consensus on the meaning of Sys-
tems Medicine. In the 67 papers containing definitions
of Systems Medicine or definition-like text passages,6 we
found 98 definitions with 114 means and 132 ends,
depicted in Tables 2 and 3.7 We did not carry out a
word-by-word analysis to find out the semantic overlap
of all definitions and definitions-like text passages found
in the literature. This would have been outside our ap-
proach which aimed to analyze all definitions and
definition-like-text passages by way of building inductive
categories and the applying the six formal criteria to the
single elements. Furthermore, we did not seek for a
consensus definition.
Step 3: Development of a précising definition of systems
medicine
After applying our criteria (2)–(6) for determining the ad-
equacy of definitions (non-circularity, non-redundancy,
consistency, non-vagueness, and coherence) to the ends of
Systems Medicine found in the literature and excluding all
ends not meeting the criteria,8 we inductively assigned the
remaining ends to the following preliminary categories9:
End i) Improving Participation
End ii) Improving Prediction
End iii) Improving Prevention
End iv) Improving Stratification
End v) Improving Treatment
End vi) Improving Diagnostics
End vii)Modelling
End viii) Improving Understanding of Disease/
Pathologies/Health States
End ix) Innovative Approach to Drug Discovery
End x) Finding Novel Therapeutic Targets
End xi) Discovering New Diagnostic and Prognostic
Biomarkers
End xii)Re-Defining Clinical Phenotypes
End xiii) Improving Health Care
End xiv) Achieving better Population Health
Categories Ends ii) (Improving Prediction), iii) (Im-
proving Prevention), v) (Improving Treatment) and vi)
(Improving Diagnostics) are classical ends with regard
to improving health care. Accordingly, we assigned
them to category End xiii) (Improving Health Care).
Categories End x) (Finding Novel Therapeutic
Targets), xi) (Discovering New Diagnostic and Prog-
nostic Biomarkers) and xii) (Re-Defining Clinical Phe-
notypes) were subsumed under category End iv)
(Improving Stratification). With regard to category
End x) (Finding Novel Therapeutic Targets), this deci-
sion followed the insight that it is a particular goal of
Table 2 Means of Systems Medicine in the literature
combines systems biology and pathophysiological approaches to
translational research, integrating various bio-medical tools and
using the power of computational and mathematical modelling
using molecular and dynamic parameters
inferred models
incorporating genomic information (genomic medicine) along with
appropriate biological and computational tools for data interpretation
leverages systems biology for clinical application
information and communication technologies, and the conceptual
framework of complex system studies
shedding light in multiple research scenarios, ultimately leading to
the practical result of uncovering novel dynamic interaction networks
that are critical
clinical and molecular know-how
scrutinizing overall molecular network interactions, rather than
individual molecules
an implementation of Systems Biology in the Medical disciplines
implies the establishment of a connection between a molecular-
centered to a patient-centered world, through an organ-centered
intermediate layer. This mapping requires the extensive use
of computational tools such as statistical, mathematical and
bioinformatical techniques
through a shifting paradigm, starting from a cellular, toward a patient
centered framework. According to this vision, the three pillars of SM
are Biomedical hypotheses, experimental data, mainly achieved by
Omics technologies and tailored computational, statistical and
modeling tools. The three SM pillars are highly interconnected,
and their balancing is crucial
is deeply related to complex networks: it involves a systemic view
of the organism where the various building elements are considered
in their interplay
with all of a patient’s medical data being computationally integrated
and accessible to functionally interpret omics and big data
incorporating a range of personalized data including genomic,
epigenetic, environmental, lifestyle and medical history
To achieve these goals, precision medicine aims to develop
computational models that integrate data and knowledge from
both clinic and basic research to gain a mechanistic understanding
of disease
Systems medicine analyzes the dynamic data cloud that surrounds
each patient and uses this
rely on data as the primary modeling material, not knowledge
which purports to design multiscale mathematical disease models
is concerned with the network of molecular interactions that define
biological processes. Additionally, disease states are viewed as a
perturbation of these molecular networks
amalgamates systems biology techniques with medical treatment
decision-making, where information from many biological measurements
is combined and analysed for complex patterns of change.
Systems medicine is not simply the application of systems biology in
medicine; rather, it is the logical next step and necessary extension of
systems biology with more emphasis on clinically relevant applications.
Building on the success of systems biology, systems medicine is
defined as an emerging discipline that integrates comprehensively
computational modeling, ‘omics data, clinical data, and environmental
factors
utilizes all types of nonlinear information
where traditional model-driven experiments are informed by
data-driven models in an iterative manner
molecular fingerprints resulting from biological networks perturbed
by the disease will be used
the use of network-based models of biological process combined with
the information on the patient, mainly of molecular origin
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Table 2 Means of Systems Medicine in the literature
(Continued)
integrates physiopathology, network biology and molecular variations
through stratification of patients and diseases
data are collected from all the components of the immune system,
analyzed and integrated
embraces this paradigm [Systems Biology]
a) taking advantage and emphasizing information and tools made
available by the greatest possible spectrum of scientific
disciplines
b) standardization, information, integration, monitoring and
personalization
application of systems biology to medical research and practice
analyzing the interactions between the different components within
one organizational level (genome, transcriptome, proteome), and
then between the different levels
combining omics with bioinformatics, as well as functional and clinical
studies
representing all the available knowledge on the disease of interest
with a mathematical symbolism allowing generation and testing of
hypotheses through computational simulation and experimental validation
integrate a variety of data at all relevant levels of cellular organisation
with clinical and patientreported disease markers, using the power of
computational and mathematical modelling
applies the perspective of SB [Systems Biology] to the study of disease
mechanisms
a) network-based approach to analysis of high-throughput and
routine clinical data to predict disease mechanisms to
diagnoses and treatments
b) interdisciplinary approach that integrates research data and
clinical practice and others view it as fusion of systems biology
and bioinformatics with a focus on disease and the clinic
c) high-precision, mathematical model of variables from different
genomic layers that relate to clinical outcomes such as
treatment response
a) interdisciplinary approach that integrates data from basic
research and clinical practice
b) close integration of data generation with mathematical
modeling
c) development of concepts, methods and tools that support
the integration of organizational levels
a) interdisciplinary effort
b) applies the tools and concepts from systems biology and
addresses complexity in two key ways. First, systems medicine
uses molecular diagnostics to stratify patients and diseases
c) applying a network-level view of disease
d) identifying important functional and regulatory modules within
these networks
e) by analyzing and targeting hubs—the most highly
interconnected nodes—within these regulatory networks, and
enzymatic activity in metabolic networks
a) iterative and reciprocal feedback between data-driven
computational and mathematical models as well as
model-driven translational and clinical investigations
b) specific but large and static data sets acquired across multiple
modalities are used
based on theoretical methods and high-throughput “omics” data
a) statistical and computational analysis of metabolic, phenotypic,
and physiological data
b) application of computational and statistical approaches to
support clinical decisions
a) tools for data integration
Table 2 Means of Systems Medicine in the literature
(Continued)
b) sophisticated measurement of molecular moieties
united genomics and genetics through family genomics
different specific complex factors are important in disease management
and that these factors need to be incorporated in some meaningful way
standardization of data
integrating experiments in iterative cycles with computational modeling,
simulation, and theory
a) identifying all the components of a system, establishing their
interactions and assessing their dynamics – both temporal and
spatial – as related to their functions
b) utilizes all types of biological information – DNA, RNA, protein,
metabolites, small molecules, interactions, cells, organs,
individuals, social networks and external environmental
signals – integrating them
the fully implementation of which requires marrying basic and clinical
researches through advanced systems thinking and the employment of
high-throughput technologies in genomics, proteomics, nanofluidics, single-
cell analysis, and computation strategies in a highly-orchestrated discipline
using the power of computational and mathematical modeling
using knowledge of their molecular components must exploit more
limited data sets, arising from multiple open-ended investigations
upon highly heterogeneous patient populations in conjunction with
vast amounts of poorly correlated published results. Hence, systems
medicine must proceed on the basis of existing, highly heterogeneous
data and not on the basis of homogeneous datasets arising from
specifically targeted investigations.
companion molecular diagnostics for personalized therapy the mounting
influx of global quantitative data from both wellness and diseases,
which requires new strategies, both scientific and organizational
by determining the links between genotypes, phenotypes and
environmental factors (e.g. diet and exposure to toxins)
by analysing its different constituents
emphasizes the role of systems biology in medical/clinical applications
With the advent of new technologies, the “omics” explosion (i.e., next
generation sequencing) and the induced changes from data-poor to
data-rich applications (for instance related to high-content imaging,
physiology, and structural biology) have established the necessity of
a systems approach (Noble, 2008
Systems medicine represents a mosaic of distinct and interconnected
micro-systems
originated by a variety of information sources and consequently
characterized.
leverages complex computational tools and high-dimensional data
the effective use of petabytes of data, which necessitates the
development of both new types of tools and a new type of
physician—one with a grasp of modern computational sciences,
“omics” technologies, and a systems approach to the practice of
medicine systems biology
This proposed holistic strategy involves comprehensive patient-centered
inte
grated care and multi-scale, multi-modal and multi-level systems
approaches
Rather than studying each disease individually, it will take into account
their intertwined gene-environment, socio-economic interactions and
co-morbidities that lead to individual-specific complex phenotypes.
based on a robust and extensive knowledge management infrastructure
that contains individual patient information.
It will be supported by strategic partnerships involving all stakeholders,
including general practitioners associated with patient-centered care. This
systems medicine strategy, which will take a holistic approach to disease
It uses the power of computational and mathematical modeling].
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modern efforts of stratification to base therapeutic
measures on novel targets, i.e. targets identified
through methods of molecular specification [20–22].
A similar point can be made for categories End xi)
(Discovering New Diagnostic and Prognostic Bio-
markers) and xii) (Re-Defining Clinical Phenotypes): it
is a declared goal of activities to improve stratification
(for instance through so called Personalized, Individu-
alized or Precision Medicine approaches), to stratify
diseases into smaller subgroups by using (new diag-
nostic and prognostic) biomarkers [16, 23]. Another
goal of stratification, which is particularly associated
with the molecular approach of Personalized Medi-
cine, is to re-interpret clinical phenotypes, e.g.
through a new specification and classification of tu-
mors on a molecular basis [24]. These considerations
left us with the following categories of Systems Medi-
cine ends:
End a) Improving Participation
End b) Improving Stratification
End c) Modelling
End d) Improving Understanding of Diseases/
Pathologies/Health States
End e) Innovative Approach to Drug Discovery
End f) Improving Health Care
End g) Achieving better Population Health.
In a next step, we applied our criteria (2)–(6) (non-cir-
cularity, non-redundancy, consistency, non-vagueness,
and coherence) to the means found in the literature on
Systems Medicine and excluded all means not meeting
Table 2 Means of Systems Medicine in the literature
(Continued)
takes a holistic view of health and disease through integrated care
using multidisciplinary and teamwork approaches centered in primary
and community
Understanding the unique events in an individual’s life as influencing
the development of illness and disease appears to be the key to what
is emerging under the names of ‘personalized medicine’ and ‘systems
medicine’.
Personalized medicine presupposes systems biology and complexity
sciences, […]
Systems biology and medicine focuses on deciphering mechanisms
at multiple levels, reconstructing networks in cells, tissues and organs,
measuring and predicting phenotypes, building quantitative models
that describe and simulate normal and pathological physiological
functions, and then testing the validity of these models and predictions
experimentally.
exploration of tumor microenvironment2,15 and of a more global approach
to link individual tumors with their multiple host variables,including heritable
causal mutations, environmental exposures and lifestyle,
the elucidation of drug targets, an important step in the search for
new drugs or novel targets for existing drugs. Incorporating multiple
biological information sources is of essence
applicable methodology tool, systems biology.
Systems medicine, the translational science counterpart to basic
science’s systems biology, is the interface at which these tools may
be constructed
[…] systems medicine is the coupling of systems science with medical
treatment decision-making.
systems medicine approaches focus on the dynamic interactions among
multiple factors that affect complex diseases, such as diabetes, coronary
artery disease and cancers1. The increasing availability of powerful
high-throughput technologies, computational tools and integrated
knowledge bases, has made it possible to establish new links between
genes, biologic functions and human diseases, providing the hallmarks
of systems medicine, including signatures of pathology biology, and
links to clinical research and drug discovery.
Holistic systems biology methodologies
through the construction of integrated biomolecular networks.
The knowledge of network dynamics through in vitro experimental
perturbation and modeling allows us to determine the state of the
networks, to identify molecular correlates, and. The transformation in
biology through systems biology
The central premise of systems medicine is that clinically detectable
molecular fingerprints resulting from disease-perturbed biological
networks will be used to detect and stratify various pathological
conditions. Disease associated molecular fingerprints will eventually
be used to group individuals into sub-populations based on variations
in genetic makeup of the population that affects disease progression.
The key to this revolution lies in harnessing the power of network
models of core biological processes learned through systems biology
methods, combined with vast amounts of diverse molecular information
generated from patient samples.
depends on our ability to: 1) precisely infer network state from the
results of assessing the levels of a panel of informative, diagnostic
biomarkers in the blood, and 2) specifically manipulate a network to
avoid or revert the pathology.
the application of our understanding of the integrated dynamical
responses of various molecular networks that determine the critical
states of the body.
the therapeutic component of systems medicine then, in which we
infer network states from biomarker measurements
the application of systems biology
incorporates the complex biochemical, physiological, and environmental
interactions that sustain living organisms.
Table 2 Means of Systems Medicine in the literature
(Continued)
incorporates interactions between all components of health and disease.
A key feature of systems medicine is that existing networks, through
dynamic (time-dependent) interactions, manifest “emergent properties”
that define the whole and that these properties are not simply the sum
of the features of its component parts.
by integrating all levels of quantitative functional, structural, and
morphological information into a coherent model.
It investigates the physiological network of diseases from gene to
organ systems
via an integrative approach that includes clinical examinations,
experimental modeling and in-silico simulation.
by integrating all levels of quantitative functional, structural and
morphological information into a coherent model.
Systems medicine is an emerging concept that acknowledges the
complexity of a multitude of non-linear interactions among molecular
and physiological variables.
Under this new paradigm, rather than a collection of symptoms,
diseases are seen as the product of deviations from a robust steady
state compatible with life.
the incorporation of mathematics and physics to the more classical
arsenal of physiology and molecular biology with which physicians are
trained today.
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Table 3 Ends of Systems Medicine in the literature
enables the personalization of diagnosis, prognosis and treatment helps
to re-define clinical phenotypes to discover new diagnostic and
prognostic biomarkers to guide the design of new clinical trials
accurately predict sensitivity of an individual tumor to a drug or drug
combination
to generate genomics informed personalized therapeutic regimes with
higher efficacy
assist in designing personalized cancer therapy treatments with
expected effectiveness significantly higher than current standard of
care approaches
to deliver P4 and precision medicine in the future. This will enable
introduction of individualized tailored prevention and/or treatment strategies
to understand the critical points of health maintanance and prevent
disease development
to aid understanding of the nonpulmonary determinants of
heterogeneity in the common and debiliating condition of chronic
obstructive pulmonary disease (COPD)
identify clinically important molecular targets for diagnostic and
therapeutic measures against such a condition influencing the course
of medical conditions to produce exquisite datasets that are employed
to generate pathway models and treatment and will hopefully directly
contribute to stratified medicine en-route to personalized healthcare
The application of systems biology for more effective and clinically
applicable research outcomes
links disease-associated genes to the phenotypes they produce, a key
goal within systems medicine.
a particular attention to clinical applications, including clinical
Bioinformatics and the discrimination of pathological states and related
morbidities and comorbidities
extension of Systems Biology to Clinical-Epidemiological disciplines
identify new patterns in the pathogenesis, diagnosis and prognosis of
chronic diseases
to achieve a shift to future healthcare systems with a more proactive
and predictive approach to medicine, where the emphasis is on disease
prevention rather than the treatment of symptoms. The individualization
of treatment for each patient will be at the centre of this approach to
facilitate their application [of omics and big data] to healthcare
provision
the aim is to treat every patient as an individual case
inform rational therapy design for each patient
thereby facilitating personalized treatment decisions
to derive “actionable possibilities” that can improve wellness or avoid
disease for each patient.
predictive, preventive, personalized, and participatory medicine
developing new diagnostic and therapeutic reagents to terminate a
disease trajectory for each individual early, returning them to wellness
aims at predicting the course of a disease in a given patient and how
far it can be altered by available therapies the prediction of benefit–risk
for a single subject, a group, or a population
the application of systems biology to medicine concerned with the
complex network interplay of a biological unit and represents injury
and illness as a perturbation to the network
aims to offer new approaches for addressing the diagnosis and
treatment of major human diseases uniquely, effectively, and with
personalized precision
to model and predict disease expression (the pathophenome). Systems
medicine integrates basic research and clinical practice, and emphasizes
translational and clinical research
highly comprehensive and integrative
aims to offer a powerful set of methodologies to improve our
understanding of disease pathogenesis and to design personalized
therapies to address the complexity of human diseases
the clinical application of Systems Biology approaches to medicine
Table 3 Ends of Systems Medicine in the literature (Continued)
to detect and stratify various pathological conditions providing novel
insights into the mechanisms of various diseases, such as diabetes and
obesity, overcoming the current limitations of disease complexity
a) to generate a mathematical model that describes or predicts
the response of the system to individual perturbations
b) interdisciplinary approach that systematically describes the
complex interactions between all parts of a biological system,
with a view to elucidating new biological rules capable of
predicting the behavior of the biological system
adaptation and extension of Systems Biology
aimed at improving risk prediction and individual treatment respecting
ethical and legal requirements
to find novel diagnostic markers
to find novel therapeutic targets
innovative approach to complex diseases understanding and drug
discovery
enable the understanding of the mechanisms, prognosis, diagnosis and
treatment of disease
improving the diagnostic process, disease management, and outcomes
a) gain a translational understanding of the complex mechanisms
underlying common diseases
b) to address the problem that a disease is rarely caused by malfunction of
one individual gene product, but instead depends on multiple gene
products that interact in a complex network
c) natural extension of, or is complementary to, current models for
clinical decision-making
a) improve our understanding and treatment of diseases
b) further development of systems biology and bioinformatics
towards applications of clinical relevance
c) to derive a mechanistic understanding of pathologies,
prophylaxy and support of therapy optimization
d) develop interfaces between the computational and
mathematical frameworks used in systems medicine
a) integrate molecular, cellular, tissue, organ,
and organism levels of function into computational models
that facilitate the identification of general principles. Systems
medicine adds a disease focus.
b) to better characterize and understand disease complexity
c) to create disease networks
d) overcome current limitations in drug discovery
e) network-based approaches will be able to explore the effects
of various drugs in mathematical models
a better understanding of cellular and molecular networks as key
pathogenic elements of human diseases
a) implementation of Systems Biology approaches in medical
concepts, research and practice
b) to construct computational models for the dynamic prediction of
disease progression or response to treatment at a personal level
application of the systems biology approach to disease-focused or
clinically relevant research problems
a) provide a conceptual and theoretical framework
b) practical goal is to provide physicians the tools necessary for
harnessing the rapid advances in basic biomedical science
into their routine clinical arsenal
c) to provide the tools to take into account the complexity of
the human body and disease in the everyday medical practice
to answer clinical questions
a) clinical decision making is supported
b) integrated study of system level metabolic, phenotypic, and
physiological changes in response to disease processes or
therapies
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Table 3 Ends of Systems Medicine in the literature (Continued)
application of systems biology in a clinical context
not the mere translation of the terminology from computer and life
sciences to the medical field
a) dedicated to deciphering the control mechanisms existing
within model organisms such as yeast
b) Systems models of disease
more readily identify disease genes
treatment selection and delivery
a) application of a systems biology approach in medical research
and clinical practice
b) to intervene at an early stage to prevent the occurrence and
reduce the suffering of the effects of disease, in contrast to
chiefly targeting reactive measures only following the
occurrence of disease
c) embraces and includes programs such as P4 medicine and
personalized medicine
d) data integration from omics to the clinic
a) extension of systems biology
b) carries this approach forward into a disease-oriented era
application of systems biology approaches to medical research and
medical practice
application of systems biology to the challenge of human disease
a) a systems approach to health and disease
b) to lead to predictive and actionable models for health and
disease
predictive, preventive, personalized, and participatory (P4) medicine
translational systems medicine
to integrate a variety of biological/medical data on all relevant levels
of cellular organization, to enable an understanding of the
pathophysiological mechanisms, prognosis, diagnosis and treatment
of disease to represent signs and symptoms of diseases in multi-level
computational models of cells, tissues, organs, organ systems and even
organisms the application of systems biology approaches to medical
research and medical practice molecular) systems biology in medicine
to reconstruct organs and organisms to determine clinical behaviours
and interventions
a holistic approach to medicine (systems medicine), that could benefit
patients and society
is shaping up a transformational paradigm in medicine we termed
predictive, preventive, personalized, and participatory (P4) medicine
to enable bringing this revolution in medicine to patients and to the
healthcare system.
The reconstruction of such biological network models, the combination
of these models with omics data and their application to specific
medical questions are often referred to as systems medicine.
a better understanding of the structure and function of the human
genome and its associations
helps to understand the behaviour of the human body at all levels of
organization
it offers the prospects of modelling complex diseases, establishing novel
diagnostic and therapeutic techniques, identifying new drug targets,
developing a system-orientated drug design strategy and
eventually achieving effective personalized medicine
not to be caught in the data deluge.
allowing to infer the macro-systems dynamics and produce elements
of synthesis such as signatures and profiles
an application of systems biology approaches to biomedical problems
in the clinical setting,
to derive personalized assessments of disease risk more effective
individualized diagnosis, prognosis, and treatment options the
Table 3 Ends of Systems Medicine in the literature (Continued)
foundation for a practice of systems medicine in the future that will
be predictive, personalized, preventive, and participatory
Systems or ‘P4’ medicine offers a grand vision for achieving better
population health. The four Ps - predictive, preventive, personalized
and participatory - invoke a patient-centered approach that prioritizes
health promotion over disease treatment
to tackle NCDs as a common group of diseases. for predictive,
preventive, personalized and participatory (P4) medicine designed to
allow the results to be used globally, taking into account the needs
and specificities of local economies and health systems.
Systems medicine is the application of systems biology to medical
research and practice.
to integrate a variety of data at all relevant levels of cellular organization
with clinical and patient-reported disease markers.
to enable understanding of the mechanisms, prognosis, diagnosis and
treatment of disease.
It involves a transition to predictive, preventive, personalized and
participatory (P4) medicine, which is a shift from reactive to prospective
medicine that extends far beyond what is usually covered by the term
personalized medicine
to tackle all components of the complexity of NCDs so as to understand
these various phenotypes and hence enable prevention (Box 2), control
through health promotion and personalized medicine, and an
efficient use of health service resources
The main goal of systems medicine is to provide predictive models of the
pathophysiology of complex diseases as well as define healthy states.
Understanding drugs and their modes of action for improving the
accuracy of drug target prediction
new strategies capable of integrating all known information about the
elements that make up the reality called asthma, thus offering a
detailed mapping of its complexity.
[…] systems medicine, as a translationally relevant extension of systems
biology
promise to provide the foundation for such prospective medicine
to derive new disease treatment approaches to reverse the pathology
or prevent its progress into a more severe state through the
manipulation of network states
This general approach, including diagnostics and therapeutics, is
becoming known as systems medicine.
will enable a new medical discipline – systems medicine intervene to
halt and reverse the networks progress into an undesired state
to the prevention of, understanding and modulation of, and recovery
from developmental disorders and pathologic processes in human
health
systems medicine emphasizes that the essential purpose and relevance
of models is translational, aimed at diagnostic, predictive, and
therapeutic applications.
systems medicine aims to discover and select the key factors at each
level and integrate them into models of translational relevance, which
include measurable readouts and clinical predictions.
tries to understand perturbed physiological systems and complex
pathologies in their entirety
an integrative and systemic approach for the diagnosis, therapy, and
prevention of diseases
with four main goals — predictive, preventive, personalized, and
participative medicine (P4 medicine).
to understand perturbed physiological systems and complex
pathologies in their entirety
geared towards obtaining clinical impact with both diagnostic and
therapeutic end points.
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the criteria.10 Subsequently, we inductively derived ten
categories from the remaining means11:
Means i) Application of Systems Biology to Medical
Research and Practice
Means ii) Data Integration
Means iii)Modelling
Means iv)Networks
Means v) Bioinformatics/Computer Tools/
Computational Analysis
Means vi)Addressing Complexity
Means vii)Stratification
Means viii)Holistic Approach
Means ix)Understanding of Illnesses/Diseases
Means x) Experimental Validation/Experimental
Examination
A closer look revealed that some of these categories
do not depict adequate means of Systems Medicine
and thus have to be excluded. First, as regards
category Means iv) (Networks), it has to be stated
that, although terms like “network-based approach”
[25, 26] or “network-level view” [25] might suggest
that networks are a distinctive methodological feature
of Systems Medicine, most text passages with refer-
ence to “network” show an understanding of the term
in the sense of “physiological network”: networks are
seen as part of healthy as well as ill physiological pro-
cesses that are to be investigated rather than to be
used as a means for medical research and practice.
Networks are a structural characteristic of the physio-
logical reality that Systems Medicine seeks to under-
stand. Networks are thus object of research efforts
and cannot be a means of research at the same time.
Second, regarding category Means vi) (Addressing
Complexity), the text passages addressing complexity
state that complexity, understood as dynamic interac-
tions between multiple factors, is a fundamental
challenge of Systems Medicine calling for a distinctive
conceptual orientation. In this understanding, however,
addressing complexity cannot be seen as a specific
means for Systems Medicine research or practice. We
thus learnt that both categories, networks and address-
ing complexity, are no means but rather indicate a char-
acteristic feature of the physiological reality that Systems
Medicine seeks to investigate and understand. Further-
more, for they consist in the dynamic interactions and
interdependencies of several factors, networks can be
considered as a phenomenon of complexity and there-
fore subsumed under addressing complexity. We finally
subsumed addressing complexity, including networks,
under the category Understanding of Illness/Diseases
and considered it a specific challenge of Systems
Medicine research efforts.
Third, however, regarding category Means ix) (Under-
standing of Illnesses/Diseases), it is obvious that under-
standing of illnesses/diseases is not only a means. In
particular, this applies to medical approaches like Sys-
tems Medicine which not only refers to medical practice
but also to biomedical research. The extent to which
Systems Medicine is a biomedical research orientation,
understanding of the researched phenomena, e.g. ill-
nesses or diseases, is a primary objective. The fact that
understanding of diseases was already identified as cat-
egory End d) also indicates that Means ix) (Understand-
ing of Illnesses/Diseases) rather has to be understood as
an end of Systems Medicine.
Fourth, taking a look at category Means viii) (Holistic
Approach), it is obvious, that “holistic approach” cannot
be considered a concrete means of Systems Medicine.
Usually it is used as an attribute, assigned to the
perspective or, without specification, to the general ap-
proach of Systems Medicine, e.g. “a holistic approach to
disease”, “a holistic view of health and disease” [27]. The
precise meaning of “holistic” cannot be derived from the
respective text passages. If it is used in the sense of
“everything”, the term is relative in the sense that “every-
thing” is included, which is considered necessary for the
respective phenomenon to be investigated. However, in
this understanding, a holistic approach is rather an ideal
than a specific means of Systems Medicine.
Fifth, like category Means ix) (Understanding of Illnesses/
Diseases), category Means vii) (Stratification) was already
assigned to Systems Medicine’s ends (category End b)).
And there are good reasons for stratification of patients
and diseases not being a specific means of Systems Medi-
cine: stratification was, for instance, identified as an essen-
tial goal of Personalized Medicine [16]. With regard to
Systems Medicine, it also seems plausible to understand
stratification as an intermediate end indicating the specific
manner to achieve the ultimate overall goal of Systems
Medicine, i.e. the improvement of healthcare provision.
Therefore, we decided to exclude stratification from
Systems Medicine’s means and to treat it as an end.
These considerations left us at the following list of
Systems Medicine means categories:
Means a) Application of Systems Biology to Medical
Research and Practice
Means b) Data Integration
Means c) Modelling
Means d) Bioinformatics/Computer Tools/
Computational Analysis
Means e) Experimental Validation/Experimental
Examination
When relating categories Means a)-e) to the categories
Ends a)-g), we discovered three incoherencies: First, with
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regard to the category End a) (Participation) we found
almost no means outlining how to achieve this end; of
the 98 definitions or definition-like text passages only
two mention “patient-centered integrated care” [28], one
speaks of an “patient-centered approach” [29]. Patient-
centered care is widely understood as aiming at patients’
individual needs as well as personal preferences and
values in order to actively include them in the process of
shared decision-making [30]. However, the text passages
referring to patient-centered care consider it as part of
the strategy, i.e. the means of System Medicine. Stating
that participation (as an end) is pursued through
patient-centered care (as a means), however, does not
make sense: patient-centered care is a particular form of
participation and thus not a plausible means to realize
participation. Against this background, we conclude that
none of the mentioned means addresses the question of
how to concretely improve patients’ participation or em-
powerment in comparison to the status quo. Further-
more, it is striking that “participation” as an end in none
of the reviewed papers is mentioned sole or in combin-
ation with a semantically identical or similar term. It is
only referred to as one of the “P”s in “P4-Medicine”.
This indicates that “participation” in the context of
Systems Medicine is used as an empty phrase, which is
presumably why it has not been taken into consideration
by which means the end of (improving) participation
could be achieved. Therefore, we excluded “participa-
tion” as an end of Systems Medicine. It is important,
however, that by excluding participation (including
patient-centered care) from the ends of Systems Medi-
cine we are not suggesting on a normative level that par-
ticipation should not be pursued by Systems Medicine
approaches. The exclusion is solely due to the applica-
tion of formal criteria to currently existing definitions of
Systems Medicine in the literature.
Second, it is striking that End g) (Achieving better
Population Health) is mentioned only once [29]. Al-
though there is much academic debate on the term
“population health” [31, 32], in our understanding it des-
ignates the aim of improving public health, defined as
“the art and science of preventing disease, prolonging
life and promoting health through the organized efforts
of society” [33] and referring to “all organized measures
(whether public or private) to prevent disease, promote
health, and prolong life among the population as a
whole. Its activities aim to provide conditions in which
people can be healthy and focus on entire populations,
not on individual patients or diseases” [34]. Classical
means to improve population or public health are sur-
veillance and assessment of a population’s health and
well-being, the identification of health problems and
health hazards in a community as well as providing
health protection services (regarding, e.g., the
environment, food safety, social determinants and
economic inequalities) [34]. Among the means ana-
lyzed, however, none of such or similar means are
mentioned. Against this background, we excluded the
end “achieving better population health” due to it be-
ing not coherent with the means.
Third, category Means c) (Modelling) was also men-
tioned as category End c). If, however, the application of
Systems Biology to medical research and practice (Means
a)) is a means of Systems Medicine, modelling can only be
a means, too, for Means b)-e) (Data Integration,
Modelling, Bioinformatics/Computer Tools/Computa-
tional Analysis and Experimental Validation/Experimental
Examination) are strongly connected to system biology.
Data integration (category Means b)) means merging dif-
ferent types of data or data gained from different sources.
This aggregation of Data is an essential means of Systems
Biology: “Modern Systems Biology tackles biocomplexity
through a unique approach that integrates biological data
[…]” [35]. Such data integration, in turn, is strongly con-
nected to (mathematical) modelling (category Means c))
as part of Systems Biology: “systems biology is a method-
ology that employs mathematical modeling and computa-
tional biology tools to integrate and analyze quantitative
biological data” [36]. Against this background, we ex-
cluded modelling as an end and arrived at the following
list of categories of Systems Medicine ends:
End A) Improving Stratification
End B) Improving Understanding of Diseases/
Pathologies/Health States
End C) Innovative Approach to Drug Discovery
End D) Improving Health Care
Ends B) und C) can be assigned to a new category
“Medical research”, leaving us at the final list of Systems
Medicine Ends:
End I) Improving Stratification
End II) Improving Medical Research
End III)Improving Health Care
Ends II) and III) show that Systems Medicine aims at
improving the classical target areas of medicine per se.
Against this background, in turn, End I) is plausibly to
be understood as an interim goal that indicates the man-
ner in which improvement shall be achieved in the areas
of medical research and health care.
Returning to our list of Systems Medicine means
categories, both data integration and (mathematical)
modelling (Means b) and c)) point towards bioinfor-
matics (category Means d)) as a means of Systems
Biology: bioinformatics, defined as “advancing the
scientific understanding of living systems through
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computation” [37], includes a whole arsenal of computa-
tional means and methods of system biology such as infor-
mation management (of omics and clinical data), data
analysis and interpretation, design of new omics experi-
ments, quality control and pre-processing of omics data,
(statistical) data analysis methods of large and complex
omics-based datasets serving the goal of elucidation and
analysis of biological networks [38].
Finally, experimental validation and experimental exam-
ination (category Means e)) is a necessary supplement of
modelling in Systems Biology, as “systems biology requires
‘detail’ and hence accurate experimentation in vivo” [39].
The procedure of combining (mathematical) modelling
with in vivo experiments is an established method of
system biology tackling “biocomplexity through a unique
approach that integrates biological data, mathematical
modeling, and experimental verification in iterative feed-
back cycles” [35].
It follows that Means b)-e) are well-established means
of Systems Biology and, thus, have to be subsumed
under category Means a). This leaves us with the only
Means of Systems Medicine:
Means Application of Systems Biology to Medical
Research and Practice.
Our considerations on adequate means and ends can
finally be summarized to derive the following précising
definition of Systems Medicine:
Systems Medicine is an approach seeking to improve
medical research (i.e. the understanding of complex pro-
cesses occurring in diseases, pathologies and health states
as well as innovative approaches to drug discovery) and
health care (i.e. prevention, prediction, diagnosis and
treatment) through stratification by means of Systems
Biology (i.e. data integration, modeling, experimentation
and bioinformatics).
It is apparent that neither the means, as already estab-
lished in the context of Systems Biology, nor the ends of
Systems Medicine, especially stratification, are for them-
selves new elements of medical research and practice.
Novelty, nevertheless, results from the specific combin-
ation of these means and ends. Thereby, our definition
meets the first criterion for adequate definitions (neces-
sity). Furthermore, our previous analysis and iterative
critical comparison of means and ends shows that cri-
teria 2–6 (non-circularity, non-redundancy, consistency,
non-vagueness, and coherence) are also met.
Discussion
43% of the papers with reference to disease focus on
cancer contexts (hematological or solid cancers), 82% of
these papers present research results. This suggests that
development of Systems Medicine is most advanced in
the area of oncology. 45% of the papers on Systems
Medicine, however, have a programmatic alignment,
which shows that the description of general future pros-
pects, potentials and challenges play an important role
in ongoing works on Systems Medicine. Accordingly, a
variety of articles are of general and visionary nature.
This, in combination with the fact that 58% of all papers
have no reference to a specific disease, implies that Sys-
tems Medicine is rather in an early stage of development
and not (yet) part of everyday biomedical research and
practice. Moreover, almost half of the papers on Systems
Medicine research do not refer to any diseases. This
strengthens the impression of Systems Medicine’s vision-
ary character: much research on Systems Medicine
seems to be basic research rather than translational or
clinical research. Furthermore, we found no evidence for
Systems Medicine being part of health care practice. The
temporal distribution of publications on Systems Medi-
cine can be interpreted similarly as it indicates no major
changes in scientific publishing with regard to thematic
focus. This may be due to issues regarding methods as
well as feasibility that are direct consequences of the
Systems Biology approach [7].
Against this background, it is vital to avoid unrealistic
expectations regarding Systems Medicine approaches.
This especially holds for goals like improving patient par-
ticipation which are intensely debated in the context of
Systems Medicine: Although our analysis showed that im-
proving participation is referred to in the scientific com-
munity, we found no respective proposals for adequate
means by which this goal could be achieved. Similar to the
debates on the meaning of Personalized or Precision
Medicine [16], the vision of Systems Medicine – due to its
focus on approaches of the natural sciences and bioinfor-
matics – does not focus on wants or preferences of indi-
vidual patients, but rather on physiological needs.
Our précising definition also shows that the vision of
Systems Medicine, first, aims at improving all classical
target areas of health care (i.e. prevention, prediction,
diagnosis and treatment) through stratification. Second,
it aims at improving biomedical research through a
specific research orientation, namely understanding of
complex processes occurring in health and diseases by
means of Systems Biology. It is highly plausible to
consider Systems Medicine a comprehensive approach
addressing both biomedical research and health care
and aiming at advancements in both research and
health care. Progress in health care relevant stratifica-
tion is attainable only through the discovery, under-
standing and development of new biomarkers as well
as new targeted therapies.
Regarding its focus on stratification, Systems Medicine
indeed can be understood as some kind of successor of
Personalized or Precision Medicine: Systems Medicine ad-
dresses the same, or at least similar goals as Personalized
or Precision Medicine. It differs, however, regarding its
Schleidgen et al. BMC Health Services Research  (2017) 17:761 Page 13 of 16
means: while Personalized Medicine focused on utilizing
biological information and biomarkers on the molecular
level in order to improve stratification of health care [16,
40], Systems Medicine focuses on means of Systems
Biology.
Admittedly, this conclusion is not without difficul-
ties, given that Systems Biology, as it is practiced
today, is a relatively young discipline differently de-
fined and understood. However, Systems Biology is
now fully established in the life sciences community
and evolved into a worldwide recognized discipline
[35]. As opposed to Systems Medicine there is a
general consensus on its key elements amongst the
scientific community. Our understanding of Systems
Biology is based on the following descriptions reflect-
ing these key elements: Systems Biology is based on
the principles of systems theory. Bridging biological
sciences, applied mathematics as well as computa-
tional and engineering sciences, it is focused on a
systemic understanding of biological processes. It em-
ploys mathematical modeling and computational biol-
ogy tools to integrate and analyze quantitative
biological data [35, 36].
The frequent statement that Systems Medicine is the ap-
plication of Systems Biology in medical research and prac-
tice thus clearly points in the right direction and is
confirmed by our findings – as long as Systems Biology and
its typical means are specified. It is important, however, to
keep in mind that stratification in the context of Systems
Medicine is not to be understood as an end in itself, but ra-
ther as an intermediate goal referring to the ultimate end of
improving medical research and health care.
Conclusions
Our literature review revealed 67 papers containing 98
definitions of Systems Medicine, which mention 114
means and 132 ends of Systems Medicine. By applying
six criteria for adequate definitions to these means and
ends (non-circularity, non-redundancy, consistency,
non-vagueness, and coherence), we derived the following
précising definition:
Systems Medicine is an approach seeking to improve
medical research (i.e. the understanding of complex pro-
cesses occurring in diseases, pathologies and health states
as well as innovative approaches to drug discovery) and
health care (i.e. prevention, prediction, diagnosis and
treatment) through stratification by means of Systems
Biology (i.e. data integration, modeling, experimentation
and bioinformatics).
Our study also revealed the visionary character of Sys-
tems Medicine: most papers presenting research results
are to be located in the context of basic research. These
insights allow for a realistic identification of actual eth-
ical as well as legal issues arising in the context of
Systems Medicine and, in consequence, for a realistic de-
bate of questions concerning its matter and (future)
handling.
It is important that our definition is not a “consensus
definition”: our literature analysis reveals that there is no
consensus on the meaning of “Systems Medicine”.
Against this background, our approach of developing a
definition of Systems Medicine combines two different
approaches of determining the meaning of a term: one
being not normative at all by confining itself to recon-
structing the meaning(s) attributed to a term by the
members of a community when using the term, and one
being highly normative by postulating the “right”
meaning of a term, independently from how it is used in
practice. It has a reconstructive aspect in starting from
definitions or definition-like passages as used or pro-
posed by members of the scientific community. On the
other hand, it also has a normative aspect when requir-
ing all (elements of ) definitions to meet six formal cri-
teria of an adequate definition. The fact that we only
worked on what people had stated and that we did not
include content elements by our own might be seen as a
“democratic” or consensus oriented procedure. However,
we excluded all definitional elements which did not meet
our six criteria. Hence, consensus was neither a goal nor
a criterion.
Limitations
The definition presented above is to be understood as
formally adequate, insofar it satisfies our six criteria for
adequate definitions. On the other hand, as regards con-
tent, we do not claim that it is the only correct definition
of Systems Medicine.
Endnotes
1The methods presented here are based on the ap-
proach developed in [16]. Differences in methods result
from taking into account applicable critiques of the
original account [41].
2https://meshb.nlm.nih.gov/record/ui?ui=D013597.
3As stated above, medical applications can be defined
by the means they employ to reach certain ends. From
this it can be inferred that defining a medical term is ne-
cessary if either (1) new medical means (or new combi-
nations of medical means) are employed to reach
conventional ends, or (2) conventional medical means
are employed to reach new ends, or (3) new medical
means (or new combinations of medical means) are
employed to reach new ends.
4See Additional file 1 for an overview of all the papers
identified.
5See Additional files 2, 3, 4, 5, 6, 7, 8 and 9.
6See Additional file 10 for an overview of all defini-
tions and definition-like text passages identified.
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7See Additional file 11 for a list of all definitions separ-
ately divided into ends and means.
8See Additional file 12.
9See Additional file 13.
10See Additional file 14.
11See Additional file 15.
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